208 related articles for article (PubMed ID: 11176072)
1. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.
Jacobs TW; Pliss N; Kouria G; Schnitt SJ
Am J Surg Pathol; 2001 Feb; 25(2):229-36. PubMed ID: 11176072
[TBL] [Abstract][Full Text] [Related]
2. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.
Maluf HM; Swanson PE; Koerner FC
Am J Surg Pathol; 2001 Feb; 25(2):237-44. PubMed ID: 11176073
[TBL] [Abstract][Full Text] [Related]
3. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
Gomes DS; Porto SS; Rocha RM; Gobbi H
Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
[TBL] [Abstract][Full Text] [Related]
6. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
Simpson JF; O'Malley F; Dupont WD; Page DL
Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
9. Biological profile of in situ breast cancer investigated by immunohistochemical technique.
Albonico G; Querzoli P; Ferretti S; Rinaldi R; Nenci I
Cancer Detect Prev; 1998; 22(4):313-8. PubMed ID: 9674874
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.
Li X; Schwartz MR; Ro J; Hamilton CR; Ayala AG; Truong LD; Zhai QJ
Int J Clin Exp Pathol; 2014; 7(5):2551-7. PubMed ID: 24966968
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
Yang G; Guo L; Jin H; Li J; Ding H
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
13. Mammographically detected in situ lobular carcinomas of the breast.
Sapino A; Frigerio A; Peterse JL; Arisio R; Coluccia C; Bussolati G
Virchows Arch; 2000 May; 436(5):421-30. PubMed ID: 10881735
[TBL] [Abstract][Full Text] [Related]
14. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
15. Rabbit monoclonal E-cadherin antibody: A cost-effective alternative to mouse monoclonal antibody in distinguishing ductal carcinoma in situ from lobular carcinoma in situ.
Baum JE; Croyle JA; Brodsky VB; Liu Y; Shin SJ
Breast J; 2019 Sep; 25(5):813-822. PubMed ID: 31165568
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
19. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
20. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]